This inventor holds 8 USPTO granted patents and 5 published patent applications. Top assignees: Cornell University, Sloan-Kettering Institute for Cancer Research. Active years: 2009-2025.
Location History:
- Old Chatham, NY (US) (2017)
- New York, NY (US) (2009 - 2024)
Company Filing History:
8 out of 2,948 
2 out of 518 
Years Active: 2009-2025
Title: David C. Lyden: Innovator in Cancer Detection and Treatment
Introduction
David C. Lyden is a prominent inventor based in New York, NY (US), known for his significant contributions to cancer research and treatment. With a total of 8 patents, he has developed innovative methods that enhance the diagnosis and management of cancer. His work focuses on utilizing exosomes and nanoparticles to improve cancer detection and treatment strategies.
Latest Patents
One of his latest patents is titled "Nanoparticles and distinct exosome subsets for detection and treatment of cancer." This invention outlines methods for diagnosing, prognosing, and managing cancer treatment in subjects. The process involves selecting a subject with cancer and obtaining a population of exosomes based on their size. These exosomes are then analyzed for various proteins, N-glycans, lipids, and genetic mutations associated with cancer, allowing for tailored treatment approaches.
Another notable patent is "Methods and reagents for determination and treatment of organotropic metastasis." This invention describes methods and kits for prognosing and treating cancer by analyzing exosomes or S100 molecule-containing samples. The detection of integrins and S100 molecules aids in the prognosis and management of cancer treatment.
Career Highlights
David C. Lyden has worked with esteemed institutions such as Cornell University and the Cornell Research Foundation Inc. His research has significantly impacted the field of oncology, particularly in understanding the role of exosomes in cancer progression and treatment.
Collaborations
Throughout his career, David has collaborated with notable colleagues, including Hector Peinado Selgas and Haiying Zhang. These partnerships have further advanced his research and contributed to the development of innovative cancer therapies.
Conclusion
David C. Lyden's work exemplifies the intersection of innovation and healthcare, particularly in the fight against cancer. His patents and research continue to pave the way for improved diagnostic and treatment methods, showcasing the vital role of inventors in advancing medical science.